BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for October 2017
Since 2007, our partners at the Movember Foundation have generously donated $44 million to PCF to support 33 research awards in the US, Canada, and Great Britain. This investment in...Read More